Publications by authors named "Roland Bugat"

Claim this Profile
T
The Impact of a Small Private Online Course as a New Approach to Teaching Oncology: Development and Evaluation.
Charlotte Vaysse, Elodie Chantalat, Odile Beyne-Rauzy, Louise Morineau, Fabien Despas, Roland Bugat, Marie-Eve Rougé Bugat

JMIR Med Educ· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of iron sucrose and red blood cell transfusions in anaemic cancer patients in France (OncoFer study).
Elisabeth Luporsi, Alain Toledano, Dominique Spaeth, Florian Scotté, Marc Espié, Roland Bugat

Support Care Cancer· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical use of ferric carboxymaltose in patients with solid tumours or haematological malignancies in France.
Alain Toledano, Elisabeth Luporsi, Jean François Morere, Florian Scotté, Kamel Laribi, Roland Bugat

Support Care Cancer· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of cost savings with ferric carboxymaltose in anemia treatment through its impact on erythropoiesis-stimulating agents and blood transfusion: French healthcare payer perspective.
Elisabeth Luporsi, Lamine Mahi, Camille Morre, Jorge Wernli, Gérard de Pouvourville, Roland Bugat

J Med Econ· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnosis and management of anaemia and iron deficiency in patients with haematological malignancies or solid tumours in France in 2009-2010: the AnemOnHe study.
Marc Spielmann, Elisabeth Luporsi, Isabelle Ray-Coquard, Stéphane de Botton, David Azria, Roland Bugat

Eur J Cancer· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality of life of palliative chemotherapy naive patients with advanced adenocarcinoma of the stomach or esophagogastric junction treated with irinotecan combined with 5-fluorouracil and folinic acid: results of a randomised phase III trial.
Desmond Curran, Carmelo Pozzo, Jerzy Zaluski, Magdalena Dank, Carlo Barone, Roland Bugat

Qual Life Res· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-reported outcomes as a component of the primary endpoint in a double-blind, placebo-controlled trial in advanced pancreatic cancer.
S Gail Eckhardt, Peter De Porre, David Smith, Joan Maurel, William P Steward, Roland Bugat

J Pain Symptom Manage· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination chemotherapy of vinorelbine and cisplatin: a phase I pharmacokinetic study in patients with metastatic solid tumors.
Jean-Pierre Delord, Christian Puozzo, Florence Lefresne, Roland Bugat

Anticancer Res· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multicenter randomized trial of adjuvant fluorouracil and folinic acid compared with surgery alone after resection of colorectal liver metastases: FFCD ACHBTH AURC 9002 trial.
Guillaume Portier, Dominique Elias, Olivier Bouche, Philippe Rougier, Jean-François Bosset, Roland Bugat

J Clin Oncol· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase-I study of a new schedule based on increasing days of topotecan administration associated with dose individualisation.
Jean-Pierre Delord, Frédéric Léger, Pierre Canal, Muriel Poublanc, Roland Bugat

Cancer Chemother Pharmacol· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cystatin C as a new covariate to predict renal elimination of drugs: application to carboplatin.
Fabienne Thomas, Sophie Séronie-Vivien, Laurence Gladieff, Florence Dalenc, Valérie Durrand, Roland Bugat

Clin Pharmacokinet· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vivo and in vitro antitumor activity of oxaliplatin in combination with cetuximab in human colorectal tumor cell lines expressing different level of EGFR.
Diane Balin-Gauthier, Jean-Pierre Delord, Philippe Rochaix, Valérie Mallard, Fabienne Thomas, Roland Bugat

Cancer Chemother Pharmacol· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oxaliplatin combined with 5-FU in second line treatment of advanced pancreatic adenocarcinoma. Results of a phase II trial.
Emmanuel Mitry, Michel Ducreux, Mahmoud Ould-Kaci, Valérie Boige, Jean-François Seitz, Roland Bugat

Gastroenterol Clin Biol· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Advanced ovarian cancer: a need for redefining therapeutic objectives and strategy].
Roland Bugat, Jean-Paul Guastalla, Jean-Louis Misset

Bull Cancer· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Recommendations for the management of GIST patients].
Jean-Yves Blay, Bruno Landi, Sylvie Bonvalot, Geneviève Monges, Isabelle Ray-Coquard, Roland Bugat

Bull Cancer· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Irinotecan plus oxaliplatin and leucovorin-modulated fluorouracil in advanced pancreatic cancer--a Groupe Tumeurs Digestives of the Federation Nationale des Centres de Lutte Contre le Cancer study.
Thierry Conroy, Bernard Paillot, Eric François, Roland Bugat, Jacques-Henri Jacob

J Clin Oncol· February 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics of platinum after oral or intravenous cisplatin: a phase 1 study in 32 adult patients.
Saik Urien, Etienne Brain, Roland Bugat, Xavier Pivot, Isabelle Lochon

Cancer Chemother Pharmacol· January 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanism-based models for topotecan-induced neutropenia.
Frédéric Léger, Walter J Loos, Roland Bugat, Ron H J Mathijssen, Marine Goffinet

Clin Pharmacol Ther· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Standards, Options and Recommendations 2004: good practice guidelines for second opinion in anatomic and surgical pathology in oncology (integral report)].
J Hassoun, Anne Bataillard, Jean-Jacques Voigt, Jean-Marie Coindre, E Anger, Roland Bugat

Bull Cancer· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic linearity of i.v. vinorelbine from an intra-patient dose escalation study design.
David Khayat, Olivier Rixe, René Brunet, Alain Goupil, Roland Bugat

Cancer Chemother Pharmacol· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[For a coordination of the supportive care for people affected by severe illnesses: proposition of organization in the public and private health care centres].
Ivan Krakowski, François Boureau, Roland Bugat, Laurent Chassignol, Philippe Colombat

Bull Cancer· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Demography of oncologic practitioners working in France. Projection elements for the next 30 years].
P Rivera, Jean-Pierre Delord, P Grosclaude, A Grand, Roland Bugat

Bull Cancer· March 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epoetin alfa and intravenous iron sucrose to treat severe anemia in a patient with chronic radiation enteropathy: a case report.
Sophie Séronie-Vivien, Loïc Mourey, Moustapha Tohfe, Roland Bugat

Med Oncol· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vinorelbine-related cardiac events: a meta-analysis of randomized clinical trials.
Maryse Lapeyre-Mestre, Nicolas Gregoire, Roland Bugat, Jean-Louis Montastruc

Fundam Clin Pharmacol· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Clinical practice guidelines: Standards, Options and Recommendations for the diagnosis of carcinomas of unknown primary site].
Thierry Lesimple, Jean-Jacques Voigt, Anne Bataillard, Jean-Michel Coindre, Stéphane Culine, Roland Bugat

Bull Cancer· December 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis